GUTS

A class action lawsuit has been filed against Fractyl Health, Inc. for allegedly making materially false and misleading statements about its Revita product's effectiveness and clinical trial integrity during the Class Period of January 13, 2025 to January 29, 2026. Investors with losses are urged to contact the law firm before the October 20, 2026 lead plaintiff deadline. Similar lawsuits have also been filed against Taboola.com Ltd., AEVEX Corp., and Coastal Financial Corporation.

A class action lawsuit has been filed against Fractyl Health, Inc. (NASDAQ: GUTS) alleging that the company made materially false and misleading statements regarding its Revita product's effectiveness and clinical trial integrity. Investors who purchased Fractyl securities between January 13, 2025 and January 29, 2026 have until October 20, 2026 to apply as lead plaintiff.

A class action lawsuit has been filed against Fractyl Health, Inc. (NASDAQ: GUTS) alleging that company executives made materially false and misleading statements regarding the effectiveness of its Revita product and the integrity of clinical trial results. The lawsuit covers investors who purchased Fractyl securities between January 13, 2025 and January 29, 2026. The lead plaintiff deadline is October 20, 2026.